Skip to content

the effectiveness of the Epiface syringe for confirming the epidural space in epidural anesthesia

the effectiveness of the Epiface syringe for confirming the epidural space in epidural anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1010240062
Enrollment
180
Registered
2024-12-25
Start date
2024-12-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical diseases requiring epidural anesthesia

Interventions

Patients undergoing epidural anesthesia will be randomly assigned to either the loss of resistance group or the Epiface group, and the effectiveness of the Epiface syringe for confirming the epidural

Sponsors

Sawada Atsushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Age 20 years or older 2) Gender is not restricted 3) ASA physical status I or II 4) Patients who can give informed consent before enrollment

Exclusion criteria

Exclusion criteria: 1) Patients with local anesthetic allergies 2) Patients undergoing anticoagulant therapy 3) Patients with a body mass index of 35 or greater 4) Other patients who are deemed inappropriate for this study by the attending physician

Design outcomes

Primary

MeasureTime frame
Time required to confirm the epidural space (seconds)

Secondary

MeasureTime frame
Number of punctures (times) Success rate of epidural space confirmation (%) Rate of adverse events (%)* Ease of epidural anesthesia procedure (3-level evaluation by the operator) Assurance of epidural space confirmation (3-level evaluation by the operator)

Contacts

Public ContactAtsushi Sawada

Sapporo Medical University School of Medicine

atusihon7@gmail.com+81-11-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026